{
    "nct_id": "NCT06528496",
    "official_title": "N10: Reduced Therapy for High-Risk Neuroblastoma",
    "inclusion_criteria": "* Diagnosis of NB as defined by histopathology, BM metastases plus high urine catecholamine levels, or positivity in MIBG scan.\n* HR-NB, defined as MYCN-amplified stage L2/M/MS at any age and stage M in patients >18 months old.\n* No more than one prior cycle of HR-NB chemotherapy\n* Age <19 years.\n* Signed informed consent indicating awareness of the investigational nature of this treatment.\nHealthy volunteers allowed\nMust have minimum age of 18 Months\nMust have maximum age of 19 Years",
    "exclusion_criteria": "* Severe dysfunction of major organs, i.e., renal, cardiac, hepatic, neurologic, pulmonary, hematologic, or gastrointestinal toxicity > grade 2\n* Inability to comply with protocol requirements\n* Pregnancy",
    "miscellaneous_criteria": ""
}